SKL2001

Catalog No.S8320 Batch:S832001

Print

Technical Data

Formula

C14H14N4O3

Molecular Weight 286.29 CAS No. 909089-13-0
Solubility (25°C)* In vitro DMSO 57 mg/mL (199.09 mM)
Ethanol 57 mg/mL (199.09 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description SKL2001 is a novel agonist of the Wnt/β-catenin pathway. It disrupts the Axin/β-catenin interaction.
Targets
Wnt/β-catenin [1]
(Cell-free assay)
In vitro SKL2001 upregulated β-catenin responsive transcription by increasing the intracellular β-catenin protein level and inhibited the phosphorylation of β-catenin at residues Ser33/37/Thr41 and Ser45, which would mark it for proteasomal degradation, without affecting CK1 and GSK-3β enzyme activities. SKL2001 disrupted the Axin/β-catenin interaction, which is a critical step for CK1- and GSK-3β-mediated phosphorylation of β-catenin at Ser33/37/Thr41 and Ser45. The treatment of mesenchymal stem cells with SKL2001 promoted osteoblastogenesis and suppressed adipocyte differentiation, both of which were accompanied by the activation of Wnt/β-catenin pathway. SKL2001 did not affect either NF-κB or p53 reporter activity and inhibits β-catenin phosphorylation without affecting GSK-3β activity[1].

Protocol (from reference)

Cell Assay:[1]
  • Cell lines

    HEK293 reporter and control cell lines

  • Concentrations

    20 μM

  • Incubation Time

    15 h

  • Method

    The HEK293 reporter and control cell lines were established. The HEK293 reporter cells were inoculated into 384-well plates at 10 000 cells per well and grown for 24 h. Next, each compound in the chemical library (∼270 000) was added to at a final concentration of 20 μM. After 15 h, the plates were assayed for firefly luciferase activity.

Customer Product Validation

Data from [Data independently produced by , , Lab Invest, 2018, 98(12):1527-1537]

Data from [Data independently produced by , , Life Sci, 2018, 197:91-100]

Data from [Data independently produced by , , Biochem Biophys Res Commun, 2017, 486(1):49-56]

Data from [Data independently produced by , , Biochem Biophys Res Commun, 2017(484):586e591]

Selleck's SKL2001 has been cited by 45 publications

Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency [ Nat Cancer, 2024, 10.1038/s43018-023-00716-7] PubMed: 38308117
Tumor-derived Exosomal ENO2 Modulates Polarization of Tumor-associated Macrophages through Reprogramming Glycolysis to Promote Progression of Diffuse Large B-cell Lymphoma [ Int J Biol Sci, 2024, 20(3):848-863] PubMed: 38250157
β-catenin inhibition disrupts the homeostasis of osteogenic/adipogenic differentiation leading to the development of glucocorticoid-induced osteonecrosis of the femoral head [ Elife, 2024, 12RP92469] PubMed: 38376133
Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2/β-catenin pathway [ Cell Death Dis, 2023, 14(10):696] PubMed: 37875515
Circ-CCT2 Activates Wnt/β-catenin Signaling to Facilitate Hepatoblastoma Development by Stabilizing PTBP1 mRNA [ Cell Mol Gastroenterol Hepatol, 2023, 10.1016/j.jcmgh.2023.10.004] PubMed: 37866478
Critical role for ribonucleoside-diphosphate reductase subunit M2 in ALV-J-induced activation of Wnt/β-catenin signaling via interaction with P27 [ J Virol, 2023, 97(8):e0026723] PubMed: 37582207
Adipocyte-derived CCDC3 promotes tumorigenesis in epithelial ovarian cancer through the Wnt/ß-catenin signalling pathway [ Biochem Biophys Rep, 2023, 35:101507] PubMed: 37601453
Single-cell transcriptome atlas of the human corpus cavernosum [ Nat Commun, 2022, 13(1):4302] PubMed: 35879305
PROX1 promotes breast cancer invasion and metastasis through WNT/β-catenin pathway via interacting with hnRNPK [ Int J Biol Sci, 2022, 18(5):2032-2046] PubMed: 35342346
A specific upregulated lncRNA in colorectal cancer promotes cancer progression [ JCI Insight, 2022, e158855] PubMed: 35617032

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.